US$ 27.16
glp 1 cardiovascular disease GLP-1: A Game-Changer for Heart Health in Obesity JCI - GLP-1 and the
Description
When you eat and drink less, fluids and electrolytes can drop

7 With their wide adoption into clinical practices for the treatment of obesity, perioperative clinicians are evaluating more patients taking GLP-1 RAs

These effects may be related to Saxenda-induced dehydration

Is it possible we are missing a treatment effect of Lixisenatide because of the heterogeneity present in most Parkinsons groups recruited for clinical trials (in other words Parkinsons is not one disease and we may have recruited a few different subtypes and this watered down the potential effects)

Will It Be Covered Under My Insurance Plan
